Literature DB >> 23517651

Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample.

G E Anholt1, I M Aderka, A J L M van Balkom, J H Smit, K Schruers, N J A van der Wee, M Eikelenboom, V De Luca, P van Oppen.   

Abstract

BACKGROUND: Research into age of onset in obsessive-compulsive disorder (OCD) has indicated significant differences between patients with early and late onset of the disorder. However, multiple criteria have been used arbitrarily for differentiating between early- and late-onset OCD, rendering inconsistent results that are difficult to interpret.
METHOD: In the current study, admixture analysis was conducted in a sample of 377 OC patients to determine the number of underlying populations of age of onset and associated demographic and clinical characteristics. Various measures of anxiety, depression, co-morbidity, autism, OCD, tics and attention deficit hyperactivity disorder (ADHD) symptoms were administered.
RESULTS: A bimodal age of onset was established and the best-fitting cut-off score between early and late age of onset was 20 years (early age of onset ≤19 years). Patients with early age of onset were more likely to be single. Early age of onset patients demonstrated higher levels of OCD severity and increased symptoms on all OCD dimensions along with increased ADHD symptoms and higher rates of bipolar disorder.
CONCLUSIONS: It is suggested that 20 years is the recommended cut-off age for the determination of early versus late age of onset in OCD. Early age of onset is associated with a generally graver OCD clinical picture and increased ADHD symptoms and bipolar disorder rates, which may be related to greater functional implications of the disorder. We propose that age of onset could be an important marker for the subtyping of OCD.

Entities:  

Mesh:

Year:  2013        PMID: 23517651     DOI: 10.1017/S0033291713000470

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  26 in total

Review 1.  Restricted, Repetitive Behaviors in Autism Spectrum Disorder and Obsessive-Compulsive Disorder: A Comparative Review.

Authors:  Marina Jiujias; Elizabeth Kelley; Layla Hall
Journal:  Child Psychiatry Hum Dev       Date:  2017-12

2.  Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.

Authors:  Antonio Del Casale; Georgios D Kotzalidis; Chiara Rapinesi; Paolo Girardi
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

3.  Age-at-onset subsets of bipolar I disorders: A critical insight into admixture analyses.

Authors:  Claire Montlahuc; Emmanuel Curis; Sarah Flora Jonas; Frank Bellivier; Sylvie Chevret
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-21       Impact factor: 4.035

4.  Impact of Gender, Age at Onset, and Lifetime Tic Disorders on the Clinical Presentation and Comorbidity Pattern of Obsessive-Compulsive Disorder in Children and Adolescents.

Authors:  Canan Tanidir; Hilal Adaletli; Hatice Gunes; Ali Guven Kilicoglu; Caner Mutlu; Mustafa Kayhan Bahali; Tugce Aytemiz; Ozden Sukran Uneri
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-06       Impact factor: 2.576

5.  The OCI-CV-R: A Revision of the Obsessive-Compulsive Inventory - Child Version.

Authors:  Amitai Abramovitch; Jonathan S Abramowitz; Dean McKay; Heining Cham; Kennedy S Anderson; Lara Farrell; Daniel A Geller; Gregory L Hanna; Sharna Mathieu; Joseph F McGuire; David R Rosenberg; S Evelyn Stewart; Eric A Storch; Sabine Wilhelm
Journal:  J Anxiety Disord       Date:  2022-01-15

6.  Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group.

Authors:  Premika S W Boedhoe; Lianne Schmaal; Yoshinari Abe; Pino Alonso; Stephanie H Ameis; Alan Anticevic; Paul D Arnold; Marcelo C Batistuzzo; Francesco Benedetti; Jan C Beucke; Irene Bollettini; Anushree Bose; Silvia Brem; Anna Calvo; Rosa Calvo; Yuqi Cheng; Kang Ik K Cho; Valentina Ciullo; Sara Dallaspezia; Damiaan Denys; Jamie D Feusner; Kate D Fitzgerald; Jean-Paul Fouche; Egill A Fridgeirsson; Patricia Gruner; Gregory L Hanna; Derrek P Hibar; Marcelo Q Hoexter; Hao Hu; Chaim Huyser; Neda Jahanshad; Anthony James; Norbert Kathmann; Christian Kaufmann; Kathrin Koch; Jun Soo Kwon; Luisa Lazaro; Christine Lochner; Rachel Marsh; Ignacio Martínez-Zalacaín; David Mataix-Cols; José M Menchón; Luciano Minuzzi; Astrid Morer; Takashi Nakamae; Tomohiro Nakao; Janardhanan C Narayanaswamy; Seiji Nishida; Erika Nurmi; Joseph O'Neill; John Piacentini; Fabrizio Piras; Federica Piras; Y C Janardhan Reddy; Tim J Reess; Yuki Sakai; Joao R Sato; H Blair Simpson; Noam Soreni; Carles Soriano-Mas; Gianfranco Spalletta; Michael C Stevens; Philip R Szeszko; David F Tolin; Guido A van Wingen; Ganesan Venkatasubramanian; Susanne Walitza; Zhen Wang; Je-Yeon Yun; Paul M Thompson; Dan J Stein; Odile A van den Heuvel
Journal:  Am J Psychiatry       Date:  2017-12-15       Impact factor: 18.112

Review 7.  The Age of Onset of Anxiety Disorders.

Authors:  Jasmijn M de Lijster; Bram Dierckx; Elisabeth M W J Utens; Frank C Verhulst; Carola Zieldorff; Gwen C Dieleman; Jeroen S Legerstee
Journal:  Can J Psychiatry       Date:  2016-07-09       Impact factor: 4.356

8.  Corpus callosum morphology in major mental disorders: a magnetic resonance imaging study.

Authors:  Fabrizio Piras; Daniela Vecchio; Florian Kurth; Federica Piras; Nerisa Banaj; Valentina Ciullo; Eileen Luders; Gianfranco Spalletta
Journal:  Brain Commun       Date:  2021-05-11

Review 9.  A dimensional perspective on the genetics of obsessive-compulsive disorder.

Authors:  Nora I Strom; Takahiro Soda; Carol A Mathews; Lea K Davis
Journal:  Transl Psychiatry       Date:  2021-07-21       Impact factor: 6.222

10.  The impact of the coronavirus (COVID-19) pandemic on the development of obsessive-compulsive symptoms in Saudi Arabia.

Authors:  Deemah A Alateeq; Haneen N Almughera; Tharaa N Almughera; Raghad F Alfedeah; Taeef S Nasser; Khozama A Alaraj
Journal:  Saudi Med J       Date:  2021-07       Impact factor: 1.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.